There is plenty of opportunity for medtech manufacturers in Asia, but first you need to know how to avoid costly pitfalls.

Generative AI in medtech raises questions on safety, validation, and regulatory challenges, explored in MD&M West's "GenMLP" ...

Launched in 2021, Boston-based Eyebot places its vision testing technology in popular sites like schools, grocery stores, and ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...

Medtronic CEO Geoff Martha shed some light on the company's M&A strategy this week at the J.P. Morgan Healthcare Conference.

The company is among several medical device suppliers that have established operations in Costa Rica in recent years.

As AI adoption accelerates across life sciences, many organizations are discovering that pilots alone do not deliver impact. This trends brief explores four critical AI shifts shaping quality and ...

Executives from the Marlborough, MA-based company discussed its position in the fast-growing pulsed-field ablation market.

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...

Trends for medical device manufacturers in 2026 include balancing sustainability costs, flexible automation, AI-driven ...